Techniques: Recent developments in computer-aided engineering of GPCR ligands using the human adenosine A 3 receptor as an example

Trends in Pharmacological Sciences

Volumn 26, Issue 1, 2005, Pages 44-51

  Moro, Stefano ^a   Spalluto, Giampiero ^b   Jacobson, Kenneth A ^c  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF TRIESTE   (Italy)

^c Natl Inst Diabet Digest K   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE A3 RECEPTOR; ADENOSINE A3 RECEPTOR AGONIST; ADENOSINE A3 RECEPTOR ANTAGONIST; G PROTEIN COUPLED RECEPTOR; LIGAND; RECEPTOR SUBUNIT; RHODOPSIN;

COMPUTER AIDED DESIGN; DRUG RECEPTOR BINDING; DRUG RESEARCH; DRUG TARGETING; HUMAN; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; NONHUMAN; PHARMACODYNAMICS; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN FUNCTION; RECEPTOR BINDING; RECEPTOR INTRINSIC ACTIVITY; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; COMPUTER-AIDED DESIGN; HUMANS; LIGANDS; METHODS; MODELS, BIOLOGICAL; RECEPTOR, ADENOSINE A3; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION;

EID: 11144241002     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tips.2004.11.006     Document Type: Review

References (46)

1. R.J. Lefkowitz Historical review: a brief history and personal retrospective of seven-transmembrane receptors Trends Pharmacol. Sci. 25 2004 413 422
2. J. Bockaert, and J.P. Pin Molecular tinkering of G protein-coupled receptors: an evolutionary success EMBO J. 18 1999 1723 1729
3. T.B. Patel Single transmembrane spanning heterotrimeric G protein-coupled receptors and their signaling cascades Pharmacol. Rev. 56 2004 371 385
4. P.H. McDonald, and R.J. Lefkowitz Beta-arrestins: new roles in regulating heptahelical receptors' functions Cell. Signal. 13 2001 683 689
5. O. El Far, and H. Betz G-protein-coupled receptors for neurotransmitter amino acids: C-terminal tails, crowded signalosomes Biochem. J. 365 2002 329 336
6. G. Milligan G protein-coupled receptor dimerization: function and ligand pharmacology Mol. Pharmacol. 66 2004 1 7
7. R. Fredriksson The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints Mol. Pharmacol. 63 2003 1256 1272
8. S. Filipek The crystallographic model of rhodopsin and its use in studies of other G protein-coupled receptors Annu. Rev. Biophys. Biomol. Struct. 32 2003 375 397
9. O.M. Becker G protein-coupled receptors: in silico drug discovery in 3D Proc. Natl. Acad. Sci. U. S. A. 101 2004 11304 11309
10. T. Klabunde, and G. Hessler Drug design strategies for targeting G-protein-coupled receptors Chembiochem 3 2002 928 944
11. L.T. May Allosteric modulation of G protein-coupled receptors Curr. Pharm. Des. 10 2004 2003 2013
12. S. Moro Demystifying the three dimensional structure of G protein-coupled receptors (GPCRs) with the aid of molecular modeling Chem. Commun. (Camb.) 21 2003 2949 2956
13. P. Fishman, and S. Bar-Yehuda Pharmacology and therapeutic applications of A3 receptor subtype Curr. Top. Med. Chem. 3 2003 463 469
14. B.B. Fredholm Structure and function of adenosine receptors and their genes Naunyn Schmiedebergs Arch. Pharmacol. 362 2000 364 374
15. M. Parsons Distinct cardioprotective effects of adenosine mediated by differential coupling of receptor subtypes to phospholipases C and D FASEB J. 14 2000 1423 1431
16. G. Ferguson Subtype-specific kinetics of inhibitory adenosine receptor internalization are determined by sensitivity to phosphorylation by G protein-coupled receptor kinases Mol. Pharmacol. 57 2000 546 552
17. T.M. Palmer, and G.L. Stiles Identification of threonine residues controlling the agonist-dependent phosphorylation and desensitization of the rat A(3) adenosine receptor Mol. Pharmacol. 57 2000 539 545
18. S. Rorke, and S.T. Holgate Targeting adenosine receptors: novel therapeutic targets in asthma and chronic obstructive pulmonary disease Am J Respir Med 1 2002 99 105
19. K.A. Jacobson Adenosine A3 receptors: novel ligands and paradoxical effects Trends Pharmacol. Sci. 19 1998 184 191
20. T.W. Stone Purines and neuroprotection Adv. Exp. Med. Biol. 513 2002 249 280
21. C.E. Muller Medicinal chemistry of adenosine A3 receptor ligands Curr. Top. Med. Chem. 3 2003 445 462
22. M.C. Gershengorn, and R. Osman Minireview: insights into G protein-coupled receptor function using molecular models Endocrinology 142 2001 2 10
23. S. Filipek The crystallographic model of rhodopsin and its use in studies of other G protein-coupled receptors Annu. Rev. Biophys. Biomol. Struct. 32 2003 375 397
24. E. Archer Rhodopsin crystal: new template yielding realistic models of G-protein-coupled receptors? Trends Pharmacol. Sci. 24 2003 36 40
25. K. Palczewski Crystal structure of rhodopsin: A G protein-coupled receptor Science 289 2000 739 745
26. H. Gutierrez-de-Teran Novel approaches for modeling of the A1 adenosine receptor and its agonist binding site Proteins 54 2004 705 715
27. C. Bissantz High-throughput modeling of human G-protein coupled receptors: amino acid sequence alignment, three-dimensional model building, and receptor library screening J. Chem. Inf. Comput. Sci. 44 2004 1162 1176
28. E.S. Vermeulen Characterization of the 5-HT(7) receptor. Determination of the pharmacophore for 5-HT(7) receptor agonism and CoMFA-based modeling of the agonist binding site J. Med. Chem. 46 2003 5365 5374
29. S.K. Kim Modeling the adenosine receptors: comparison of the binding domains of A2A agonists and antagonists J. Med. Chem. 46 2003 4847 4859
30. Moro, S. et al. Combined structure-based and ligand-based drug design approach as tool to define a novel 3D-pharmacophore model of human A3 adenosine receptor antagonists: pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives as a key study. J. Med. Chem. (in press)
31. A. Maconi Synthesis, biological properties, and molecular modeling investigation of the first potent, selective, and water-soluble human A(3) adenosine receptor antagonist J. Med. Chem. 45 2002 3579 3582
32. G. Pastorin Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives as adenosine receptor antagonists. Influence of the N5 substituent on the affinity at the human A3 and A2B adenosine receptor subtypes: a molecular modeling investigation J. Med. Chem. 46 2003 4287 4296
33. V. Colotta 1,2,4-triazolo[4,3-a]quinoxalin-1-one moiety as an attractive scaffold to develop new potent and selective human A3 adenosine receptor antagonists: synthesis, pharmacological, and ligand-receptor modeling studies J. Med. Chem. 47 2004 3580 3590
34. S. Tchilibon Exploring distal regions of the A3 adenosine receptor binding site: sterically constrained N6-(2-phenylethyl)adenosine derivatives as potent ligands Bioorg. Med. Chem. 12 2004 2021 2034
35. M.E. Olah Role of the second extracellular loop of adenosine receptors in agonist and antagonist binding. Analysis of chimeric A1/A3 adenosine receptors J. Biol. Chem. 269 1994 24692 24698
36. Z.G. Gao Allosteric modulation of A(3) adenosine receptors by a series of 3-(2-pyridinyl)isoquinoline derivatives Mol. Pharmacol. 60 2001 1057 1063
37. Z.G. Gao Identification by site-directed mutagenesis of residues involved in ligand recognition and activation of the human A3 adenosine receptor J. Biol. Chem. 277 2002 19056 19063
38. 3 receptor with selectively enhanced affinity for amine-modified nucleosides J. Med. Chem. 44 2001 4125 4136
39. 3 adenosine receptors. In Annual Report in Medicinal Chemistry (Vol. 38) (Doherty, A.M. ed.), pp. 121-130, Elsevier
40. K.A. Jacobson Interactions of flavones and other phytochemicals with adenosine receptors Adv. Exp. Med. Biol. 505 2002 163 171
41. S. Moro Flavonoid derivatives as adenosine receptor antagonists: a comparison of the hypothetical receptor binding site based on a comparative molecular field analysis model J. Med. Chem. 41 1998 46 52
42. 3 adenosine receptor antagonists J. Med. Chem. 40 1997 2596 2608
43. 3 adenosine receptor antagonists J. Med. Chem. 42 1999 706 721
44. 3 adenosine receptor antagonists J. Med. Chem. 45 2002 770 780
45. S. Moro Molecular modeling studies of human A3 adenosine antagonists: structural homology and receptor docking J. Chem. Inf. Comput. Sci. 38 1998 1239 1248
46. T.R. Webb The utilization of a unified pharmacophore query in the discovery of new antagonists of the adenosine receptor family Bioorg. Med. Chem. Lett. 10 2000 31 34